Amgen

Amgen Stock (AMGN) News Today: TrumpRx Drug-Price Deal, FDA Approvals, Dividend Update, and 2026 Analyst Forecasts

December 20, 2025 — Amgen Inc. (NASDAQ: AMGN) is closing out the year with a rare combination of near-term policy headlines and company-specific catalysts that matter to investors: a new U.S. drug-pricing deal tied to the TrumpRx rollout, fresh FDA

20 December 2025

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. (NASDAQ: AMGN) is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025

16 December 2025

Dividends · Financial Analysis · Investing · NASDAQ:AMGN · Pharma News · Stock Market

Amgen (AMGN) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Amgen Inc. (NASDAQ: AMGN) heads into Monday’s session (Dec. 15, 2025) after a news-heavy stretch that has reinforced two familiar pillars of the large-cap biotech story: a steady capital-return profile and a pipeline/label-expansion engine that can still surprise to the

15 December 2025

Amgen · Financial News · Investing · Market Analysis · Stock Market

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Updated: December 4, 2025 Amgen Inc. (NASDAQ: AMGN) has quietly turned into one of 2025’s standout large‑cap healthcare winners. The biotech heavyweight is trading just below fresh 52‑week highs, powered by a clean sweep of earnings beats, a deepening obesity‑drug

4 December 2025

Biotech · Financial Analysis · Investing · NASDAQ:AMGN · Pharmaceuticals · Stock Market

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Published: December 3, 2025 Amgen Inc. (NASDAQ: AMGN) is closing out 2025 on a powerful upswing. As of the close on December 3, 2025, Amgen shares finished at $345.42, up about 2% on the day, and nudged higher in after-hours

3 December 2025

Health Care Industry · Investment Strategies · Market Analysis · NASDAQ:AMGN · Pharmaceuticals · Stock Market

Amgen (AMGN) Stock Today: Earnings Momentum, Obesity Breakthroughs and Fresh December 2, 2025 Forecasts

Published: December 2, 2025 – For informational purposes only, not investment advice. Key Takeaways Amgen stock is trading around $338.67, slightly higher on the day and still near 52‑week highs after a strong run in 2025. Q3 2025 results beat

2 December 2025

Biotechnology · Earnings Reports · Forecasts · Investment Analysis · NASDAQ:AMGN · Stock Market

Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast

Updated December 1, 2025 Amgen stock at a glance on December 1, 2025 Amgen Inc. (NASDAQ: AMGN) closed today at $337.49, down about 2.3% on the session, according to real‑time quote data. StockAnalysis Despite today’s pullback, the stock has had

1 December 2025

Biotech News · Earnings Reports · Investment Strategies · Market Forecasts · NASDAQ:AMGN · Stock Analysis

Amgen (AMGN) Stock Near Record Highs Before December 1, 2025 Open: Price, News, Analyst Targets and Forecast

Amgen (AMGN) Stock Near Record Highs Before December 1, 2025 Open: Price, News, Analyst Targets and Forecast THOUSAND OAKS, Calif. – November 30, 2025 – Amgen Inc. (NASDAQ: AMGN) heads into the new trading week sitting at an all‑time closing

1 December 2025

Amgen · Financial News · Investment · NASDAQ:AMGN · Stock Analysis · Stock Market